Register here

TUESDAY MAY 21

Session 1: AMR Education and Communication

• “Breaking Down Barriers to Sustainable Antimicrobial Use in Cats”
  • Amelia Greiner Safi and Casey Cazer
• "Influences of scientific storytelling and visual narratives on antimicrobial resistance"
  • Meghan McGillin and Megan Keller
• “Bridging borders, battling bacteria: The UK's AMR National Action Plan and its international efforts across research, policy, and education”
  • Garrett Dunlap

Session Keynote

"All the mutants we could not see: Deep mutagenesis of antibiotic binding-site"

Dr. Aviram Rasouly, Senior Research Scientist, New York University & Howard Hughes Medical Institute

WEDNESDAY MAY 22

Session 2: Detection, Discovery and Delivery

• “integrated phenotypic and activity-based profiling of electrophilic fragments reveals new druggable targets for antibiotics development”
  • Mikail Abbasov
• “Antimicrobial resistance in the Fire Blight pathogen Erwinia amylovora: More than 10 years of Research Discoveries, Commercial Detection, and Extension Deliverables”
  • Kerik Cox
• “Delivering antibiotics across the eardrum by harnessing immune cells”
  • ​​​​​​​​​​​​​​Rong Yang
• "From the soil to the clinic, towards an understanding of triclosan resistance in Stenotrophomonas species"
  • ​​​​​​​​​​​​​​Anthony Hay
• “RNA liquid biopsy for infectious disease”
  • ​​​​​​​​​​​​​​Iwijn De Vlaminck
• “Detection of β-lactam resistance in staphylococci: it’s enough to mec you crazy”
  • ​​​​​​​​​​​​​​Lars Westblade

Session 3: Origins and Mechanisms of Resistance and Tolerance              

• “Heightened sensitivity to β-lactam antibiotics due to metabolic dysregulation”
  • ​​​​​​​​​​​​​​John Helmann
• “Incorporating resilience to antimicrobial resistance in early drug discovery efforts”
  • ​​​​​​​​​​​​​​Brian VanderVen
• “The role of lipid A-modifying phosphoethanolamine transferases in polymyxin resistance”
  • ​​​​​​​​​​​​​​Anna Schumann
• “Understanding salmonella capsule variations: Impact on virulence and intervention strategies”
  • ​​​​​​​​​​​​​​Gi Young Lee
• “From Commensal to pathogen: Role of enterococcal metabolic programming during surface penetration
  • ​​​​​​​​​​​​​​Diana Morales​​​​​​​

Session Keynote

“Phenotypic screening approaches for discovering mechanistically novel antibiotic leads to combat AMR”

Dr. Terry Roemer, Chair and Chief Scientific Officer, Prokaryotics, Inc.